mesoangioblast stem cells ameliorate muscle function dystrophic dogs 
duchenne muscular dystrophy remains untreatable genetic disease severely limits motility life expectancy affected children animal model specifically reproducing alterations dystrophin gene full spectrum human pathology golden retriever dog model affected animals present single mutation intron resulting complete absence dystrophin protein early severe muscle degeneration nearly complete loss motility walking ability death usually occurs year age result failure respiratory muscles report intra-arterial delivery wild-type canine mesoangioblasts vessel-associated stem cells results extensive recovery dystrophin expression normal muscle morphology function confirmed measurement contraction force single fibres outcome remarkable clinical amelioration preservation active motility data qualify mesoangioblasts candidates future stem cell therapy duchenne patients 
